Peptide alternative to antibiotics could combat antimicrobial resistance crisis
A University of Alberta research team has developed a human-derived peptide called D-GK17 that shows potential in treating antimicrobial-resistant infections by targeting biofilms. The peptide is stable, non-toxic, and effective against bacterial and fungal cells. This innovation offers a new approach to combating the growing challenge of antibiotic resistance.
Scientists at the University of Alberta have developed a new peptide, D-GK17, that shows promise in treating infections resistant to antibiotics.
This development could help address the growing problem of antimicrobial resistance, which threatens the effectiveness of current treatments.
The research offers a hopeful, innovative approach to a critical health challenge, emphasizing collaboration and scientific progress for the public good.
Upbeat Bytes summarizes in its own words and links to the original publisher — it doesn't host the article.